MENU
LSB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
LakeShore Biopharma (LSB) Ownership - Who owns LakeShore Biopharma?
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
33.77M
P/E Ratio
N/A
Total Cash
49.47M
Projected Growth
N/A
Total Debt
368.59M
Revenue
672.27M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.59
Total Debt/Equity
N/A
Revenue/Share
5.93 USD as % of share price
Fundamentals
LSB
Capitalization
33.8M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
49.5M
Total Cash/Share
2.59
Total Debt
369M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.93%
Revenue
672M
ROE
N/A
Book Value
603M
P/B Ratio
0.41
Cash Flow
N/A
Earnings
-20.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
26K
Current Ratio
1.17
Current Revenue Per Employee
125250.27
Dividends Per Share - Security
N/A
EBITDA
-220.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.92
Revenue To Assets
-15.66
Shares Held By Institutions
1.35M
Shares Outstanding - Current
19.1M
Total Liabilities
830M
Total Volume MTD
N/A
Value
1
Gain YTD
-48.844
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information